Biblio
Export 1352 results:
Author [ Title] Type Year Filters: First Letter Of Last Name is P [Clear All Filters]
“Taking the A Train? Limited Consistency of Aβ42 and the Aβ42/40 Ratio in the AT(N) Classification.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1033-1038, 2021.
, “Synthesis, Radiosynthesis, and Preliminary in vitro and in vivo Evaluation of the Fluorinated Ceramide Trafficking Inhibitor (HPA-12) for Brain Applications.”, J Alzheimers Dis, vol. 60, no. 3, pp. 783-794, 2017.
, “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
, “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
, “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
, “Sustained Hippocampal Neural Plasticity Questions the Reproducibility of an Amyloid-β-Induced Alzheimer's Disease Model.”, J Alzheimers Dis, vol. 82, no. 3, pp. 1183-1202, 2021.
, “Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 90, no. 1, pp. 233-249, 2022.
, “Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 90, no. 1, pp. 233-249, 2022.
, “Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 90, no. 1, pp. 233-249, 2022.
, “Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 90, no. 1, pp. 233-249, 2022.
, “Supplemental Retinal Carotenoids Enhance Memory in Healthy Individuals with Low Levels of Macular Pigment in A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.”, J Alzheimers Dis, vol. 61, no. 3, pp. 947-961, 2018.
, “Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.”, J Alzheimers Dis, vol. 62, no. 1, pp. 165-174, 2018.
, “Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.”, J Alzheimers Dis, vol. 62, no. 1, pp. 165-174, 2018.
, “Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.”, J Alzheimers Dis, vol. 62, no. 1, pp. 165-174, 2018.
, “Subjective Cognitive Decline May Be a Stronger Predictor of Incident Dementia in Women than in Men.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1469-1478, 2019.
, “Subjective Cognitive Decline May Be a Stronger Predictor of Incident Dementia in Women than in Men.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1469-1478, 2019.
, “Subclinical Doses of ATP-Sensitive Potassium Channel Modulators Prevent Alterations in Memory and Synaptic Plasticity Induced by Amyloid-β.”, J Alzheimers Dis, vol. 57, no. 1, pp. 205-226, 2017.
, “Subclinical Doses of ATP-Sensitive Potassium Channel Modulators Prevent Alterations in Memory and Synaptic Plasticity Induced by Amyloid-β.”, J Alzheimers Dis, vol. 57, no. 1, pp. 205-226, 2017.
, “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
, “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
, “Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.”, J Alzheimers Dis, vol. 75, no. 2, pp. 595-606, 2020.
, “Strategies for improving memory: a randomized trial of memory groups for older people, including those with mild cognitive impairment.”, J Alzheimers Dis, vol. 49, no. 1, pp. 31-43, 2016.
, “Stimulating the Activity of Amyloid-Beta Degrading Enzymes: A Novel Approach for the Therapeutic Manipulation of Amyloid-Beta Levels.”, J Alzheimers Dis, vol. 54, no. 3, pp. 891-895, 2016.
, “Stereological Quantification of Plaques and Tangles in Neocortex from Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 64, no. 3, pp. 723-734, 2018.
, “Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 3, pp. 893-910, 2019.
,